Huaizhong Health Group, Inc.
ADAD · OTC
10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $21 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $15 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | 0% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $29 | $31 | $36 | $5 |
| SG&A Expenses | $29 | $31 | $36 | $126 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $121 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $29 | $31 | $36 | $126 |
| Operating Income | -$29 | -$31 | -$36 | -$126 |
| % Margin | – | – | – | -613% |
| Other Income/Exp. Net | $0 | $0 | -$0 | $0 |
| Pre-Tax Income | -$29 | -$31 | -$36 | -$126 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$29 | -$31 | -$36 | -$126 |
| % Margin | – | – | – | -613% |
| EPS | -0.001 | -0.001 | -0.004 | -0.41 |
| % Growth | 10% | 71.4% | 99.1% | – |
| EPS Diluted | -0.001 | -0.001 | -0.004 | -0.41 |
| Weighted Avg Shares Out | 31,518 | 31,518 | 10,455 | 309 |
| Weighted Avg Shares Out Dil | 31,518 | 31,518 | 10,455 | 309 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $29 | $31 | $36 | $1 |
| EBITDA | $0 | $0 | $0 | -$126 |
| % Margin | – | – | – | -613% |